In a significant legal victory for NanoString Technologies Germany GmbH, the German Federal Patent Court has ruled in favor of the company by invalidating European Patent No. 2794928B1 (the 928 Patent) in Germany. This decision came in response to its assertion by 10x Genomics against NanoString in a patent infringement case. The court’s ruling is a major win for NanoString and Bruker Corporation, which acquired NanoString Technologies, Inc on May 6th, 2024.
Bruker Corporation, a leading provider of scientific instruments and solutions, reported a remarkable increase in revenue in the third quarter of 2023. The company’s revenue rose by 16.26% year on year, surpassing the average revenue growth of its competitors, which stood at 13.91% in the same quarter. This achievement demonstrates Bruker’s strong market position and the effectiveness of its growth strategies.
Moreover, Bruker’s profitability also exceeded that of its competitors. With a net margin of 11.94%, the company showcased higher profitability compared to its industry counterparts. This indicates Bruker’s ability to effectively manage costs and generate healthy profits in a competitive market landscape.
In terms of net income, Bruker continued to show resilience and growth. While many of its competitors experienced a contraction in net income by -62.08%, Bruker recorded a modest year-on-year growth of 0.34% in the third quarter of 2023. This performance highlights Bruker’s ability to sustain its financial stability and capitalize on market opportunities.
Over the past 12 months, Bruker has also demonstrated its market dominance, consistently maintaining a market share of 87.52%. This steady market share indicates customer loyalty and trust in Bruker’s products and services.
Overall, the recent legal victory for NanoString and Bruker, combined with their impressive financial achievements, signifies their strength and competitiveness in the scientific instruments industry. This favorable outcome from the German Federal Patent Court further solidifies their market positions and reiterates their commitment to innovation and excellence.
Comments